Case Study
Market Research & Technical Analysis – CGT Regulatory Landscape
Before Brand Strategy Was the Research That Made it Credible
The Challenge
Before brand strategy, before persona development, before messaging architecture — there is research. In the Cell & Gene Therapy market, that research requirement is unusually demanding. CGT customers are among the most technically sophisticated in life sciences. They evaluate partners on demonstrated understanding of their regulatory environment, manufacturing challenges, and analytical requirements. Superficial market knowledge doesn’t survive first contact with a Ph.D.-trained process engineer who has spent five years working through FDA CGT guidance documents.
The company entering this market needed more than a market summary. They needed deep enough technical fluency to position credibly, speak specifically, and eventually develop the strategic insights that would differentiate their messaging from competitors whose understanding was equally shallow.
MKA conducted the foundational technical and regulatory research that made the rest of the CGT engagement possible.
- Industry: Cell & Gene Therapy / Life Sciences
- Services: Regulatory Landscape Analysis, Technical Market Research, CQA Framework Analysis, Strategic Insight Development, Competitive Intelligence
- Timeline: Initial research phase; outputs fed directly into the brand strategy, persona, and messaging work that followed
- Client Profile: Established supplier preparing for CGT market entry; recognized that superficial market knowledge would not build credibility with technically sophisticated CGT buyers
Our Approach
01 | FDA Regulatory Landscape Review
We systematically reviewed the body of FDA guidance covering CGT product development, manufacturing controls, potency testing, donor eligibility, safety assessments, and IND requirements. The goal wasn’t regulatory compliance expertise — it was market insight. Understanding what regulators required of CGT developers revealed what those developers were worried about, what they needed from their supply chain, and where they were carrying risk they wanted to transfer. The review also confirmed that CGT guidance was still evolving, reflecting a nascent field where regulators and industry were jointly defining standards — an opening for a supplier who could help customers navigate uncertainty rather than just fulfill orders.
02 | Mapping the CGT Analytics Landscape
CGT analytical testing isn’t a standardized panel — requirements follow conditional logic based on therapy type, vector approach, development stage, and specific safety concerns. We mapped that decision-tree structure: not just what tests exist, but when each is needed and why. This confirmed that CGT analytics require a consultative approach rather than catalog ordering — a supplier who can explain the regulatory rationale behind a testing requirement offers something a commodity provider can’t.
03 | Critical Quality Attributes (CQAs)
We analyzed the five regulatory quality dimensions governing CGT products as an interconnected system rather than independent test categories, revealing relationships between them that shaped how the client could credibly discuss its own analytical capabilities. This systems-level understanding — rather than a checklist view — became the foundation for the technical differentiation used throughout the rest of the engagement.
The Impact
Technical credibility foundation established before market entry
The company could hold peer-level conversations with CGT scientists and engineers from its very first customer engagement, skipping the 12–18 months most new entrants spend closing that credibility gap through trial and error.
The “Purity Paradox”
The CQA analysis produced a finding no competitor had articulated: you can’t confirm Identity without first characterizing Purity. We named it the Purity Paradox — a memorable differentiation moment in customer conversations, later built directly into the messaging framework.
Consultative positioning validated
The analytics landscape mapping confirmed the market required a consultative approach, not catalog selling — shaping the client’s entire go-to-market model, from sales approach to service design to content strategy.
Content strategy directed
Understanding that CGT customers consume technical content voraciously shaped the content approach going forward — educational, regulatory-grounded material became the primary trust-building mechanism, not promotional content.
Facing a similar challenge?
Let’s discuss how we can help.